rethinkTHC Search
Menu
Study breakdown

A CHS patient improved with topical capsaicin, supporting the TRPV1 receptor theory for why hot showers help

Case ReportPreliminary evidence
The takeaway

A case report of CHS treated with topical capsaicin proposed that the condition arises from decreased TRPV1 receptor signaling due to chronic cannabis use, explaining why hot water bathing and capsaicin (both TRPV1 activators) provide relief.

Emergency physicians treating CHS; gastroenterologists; pharmacologists studying cannabinoid-TRPV1 interactions.

TRPV1 receptor model explains both the CHS mechanism and why hot baths and capsaicin help

What the researchers found

A patient with cannabinoid hyperemesis syndrome experienced symptom improvement after topical capsaicin application.

The authors proposed a novel mechanistic model: chronic cannabis use decreases signaling through the transient receptor potential vanilloid subtype 1 (TRPV1) receptor, which alters gastric motility and triggers the nausea/vomiting cycle.

This model explains the previously puzzling observation that CHS patients compulsively seek hot baths: both hot water and capsaicin activate TRPV1 receptors, temporarily restoring the signaling that chronic cannabis has dampened.

Previous models focused solely on CB1 receptor derangement, but the TRPV1 model fills gaps in understanding, including why hot bathing provides relief and why the syndrome develops only in some chronic users (who may have different baseline TRPV1 sensitivity).

Why it matters

Understanding why capsaicin and hot water work for CHS is not just academic. If the TRPV1 mechanism is correct, it suggests new therapeutic targets and explains individual differences in CHS susceptibility. It also supports capsaicin as a rational (not just empirical) treatment.

The numbers in context

Single patient improved with topical capsaicin. TRPV1 receptor is activated by marijuana, capsaicin, and heat. Chronic cannabis use proposed to decrease TRPV1 signaling.

How the study worked

Single case report with a proposed mechanistic model linking TRPV1 receptor downregulation to CHS pathophysiology.

What this study cannot tell us

Single case report. The TRPV1 mechanism is proposed but not proven. The model does not fully explain why only some chronic cannabis users develop CHS. No controlled comparison to other treatments.

How to read the evidence

Preliminary. Single case with a proposed mechanism. The TRPV1 model is plausible but requires experimental validation.

When this study was published

Published in 2018. The TRPV1 theory for CHS has gained traction and capsaicin has become an accepted treatment option.

The bigger picture

The TRPV1 hypothesis provides a unifying explanation for multiple CHS features: the nausea from cannabinoid-induced TRPV1 downregulation, the relief from hot water (TRPV1 activation by heat), and the effectiveness of capsaicin (TRPV1 agonist). This could guide development of more targeted treatments.

Questions still open

  • Can TRPV1 receptor sensitivity be measured to predict CHS risk? Would chronic capsaicin use prevent CHS in heavy cannabis users? Do TRPV1 genetic variants explain individual CHS susceptibility?

Common questions

What is TRPV1?
TRPV1 (transient receptor potential vanilloid subtype 1) is a receptor that responds to heat, capsaicin (the compound that makes chili peppers hot), and some cannabinoids. It plays roles in pain sensation, temperature regulation, and gastrointestinal motility.
How does capsaicin help CHS?
Capsaicin cream applied to the abdomen activates TRPV1 receptors, the same receptors stimulated by hot water. According to this model, chronic cannabis use downregulates TRPV1, and capsaicin temporarily restores the signaling, relieving nausea and vomiting.

Read the original research

Successful Treatment of Cannabinoid Hyperemesis Syndrome with Topical Capsaicin.

ACG case reports journal, 5, e3

Citation

Moon, Andrew M; Buckley, Sarah A; Mark, Nicholas M. (2018). Successful Treatment of Cannabinoid Hyperemesis Syndrome with Topical Capsaicin.. ACG case reports journal, 5, e3. https://doi.org/10.14309/crj.2018.3

Explore the wider topic